Heart Failure Treatment
Heart failure affects an estimated 6.5 million Americans. Patients experience
debilitating symptoms, including breathlessness, fatigue, confusion and
swelling in the legs that make everyday activities challenging and significantly
diminish their quality of life. Today, most heart failure patients are
prescribed medications intended to slow the progression of the disease
and manage their symptoms. As the condition progresses, these treatments
lose their effectiveness and the quality of life for heart failure patients
will continue to decline.
Heart Failure Device Therapy: An Alternative to Heart Failure Medication
Traditional cardiac implants, such as pacemakers, can correct the heart’s
rhythm and synchronize contractions to help improve cardiac performance
in people with heart failure. But these devices do nothing to boost the
heart’s ability to forcefully pump blood throughout the body.
Cardiac contractility modulation (CCM) is an innovative heart failure device
therapy that improves the contraction of the heart – allowing more
oxygen-rich blood to reach the body – allowing patients to experience
fewer heart failure symptoms.
Jupiter Medical Center’s electrophysiology team is using this breakthrough
technology when medications aren't enough to improve patients'
heart failure symptoms.
By improving the symptoms of heart failure, CCM therapy can help patients
feel better, so they can start doing the things they love again.
How CCM Therapy Works
CCM therapy delivers precisely timed electrical pulses to the heart that
are intended to improve the heart’s ability to contract.
CCM therapy is delivered by the Optimizer®, a device the size of a pacemaker. It is implanted during a minimally
invasive procedure while the patient is under light sedation.
During the procedure, the device is implanted under the skin of the upper
chest, along with electrical leads that are placed in the heart’s
right ventricle through the veins. The implanted device then sends precisely
calibrated and timed electrical pulses to the heart muscle during one-hour
treatment periods scheduled intermittently throughout the day.
Who May Benefit From CCM Therapy?
CCM therapy may be an appropriate option for up to 70-percent of NYHA Class
III (a classification of heart symptoms) heart failure patients who continue
to experience symptoms despite taking heart failure medications for their
Wondering if CCM therapy may be right for you? Consider these questions:
- Have you been diagnosed with heart failure by a doctor?
- Are you taking medications prescribed by your doctor to help improve your
heart failure symptoms?
- Despite taking your heart failure medications, do the symptoms of heart
failure (breathlessness, fatigue, confusion, and swelling in the legs,
etc.) prevent you from doing everyday things?
- Despite receiving any type of treatment (medications or device-based therapies,
such as an implanted pacemaker or defibrillator), do you still wish to
see your quality of life improve?
- Do you have an ejection fraction (a measurement of the heart’s pumping
efficiency) of 25-45%?
If you answered "yes" to any of these questions, you may be a
candidate for CCM therapy.
First in South Florida
Jupiter Medical Center was the first hospital in South Florida to treat
heart failure patients with CCM therapy. For more information call 561-263-2200.